S. Koga

发表

Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy

Masafumi Nakamura, K. Ohuchida, A. Fujimura, 2019, Journal of immunotherapy.

The vitamin E derivative, EPC-K1, suppresses inflammation during hepatic ischemia-reperfusion injury and exerts hepatoprotective effects in rats.

H. Iwasaka, T. Noguchi, S. Hagiwara, 2012, Journal of Surgical Research.

NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytes.

Masafumi Nakamura, A. Fujimura, Shu Ichimiya, 2020, Cellular immunology.

Amino acid removal in high‐flow and conventional continuous hemodiafiltration

T. Noguchi, S. Hagiwara, K. Goto, 2011 .

RETRACTED ARTICLE: Calcium/calmodulin-dependent kinase inhibitor induces growth inhibition, cell cycle arrest, and apoptosis in human choriocarcinoma cells

T. Ueda, N. Takai, M. Nishida, 2012, Tumor Biology.

PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor

Masafumi Nakamura, A. Fujimura, Masayo Umebayashi, 2021, Translational oncology.

Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma

Yoshifumi Yamamoto, H. Inohara, K. Aozasa, 2003, Cancer science.

Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer

Y. Miyoshi, S. Noguchi, K. Aozasa, 2003, Cancer science.

Overexpression of the Wilms' tumor gene WT1 in human bone and soft‐tissue sarcomas

H. Yoshikawa, N. Naka, Y. Tomita, 2003, Cancer science.

Risk factors for sodium valproate-induced renal tubular dysfunction

K. Kaneko, A. Araki, Takahisa Kimata, 2018, Clinical and Experimental Nephrology.

RETRACTED ARTICLE: A translocator protein ligand PK11195 shows antigrowth activity in human choriocarcinoma cells

N. Takai, M. Nishida, K. Nasu, 2012, Tumor Biology.

Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer.

Y. Miyoshi, S. Noguchi, N. Hosen, 2004, Japanese journal of clinical oncology.

C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions

Masafumi Nakamura, Y. Oda, Shu Ichimiya, 2023, Journal of Cancer.

GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer

Masafumi Nakamura, Y. Oda, A. Fujimura, 2021, Oncology reports.

Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers.

S. Miyoshi, I. Kawase, H. Hirabayashi, 2004, Neoplasma.

PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer

A. Fujimura, Katsuya Nakamura, S. Nagai, 2022, AntiCancer Research.

The Effect of Landiolol on Prevention for Supraventricular Arrhythmia after Thoracic Surgery

Y. Shikada, S. Koga, K. Oishi, 2010 .

MAML3 Contributes to Induction of Malignant Phenotype of Gallbladder Cancer Through Morphogenesis Signalling Under Hypoxia

Masafumi Nakamura, Y. Oda, Shu Ichimiya, 2023, AntiCancer Research.

Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments

A. Fujimura, Masayo Umebayashi, N. Komune, 2024, Journal of immunotherapy.

PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy target

Masafumi Nakamura, Masayo Umebayashi, T. Morisaki, 2023, Journal of Cancer Research and Clinical Oncology.

FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients

Masafumi Nakamura, Y. Oda, Shu Ichimiya, 2020, Journal of Cancer.